Cargando…

P1618: REAL-WORLD DATA ON EMICIZUMAB: CORRELATION BETWEEN DRUG PLASMA LEVELS, GLOBAL PROCOAGULANT STATUS AND SPONTANEOUS JOINT ANNUALIZED BLEEDING RATE

Detalles Bibliográficos
Autores principales:	Jaime, Francisco José López, Marco-Rico, Ana, Montaño, Adrián, López, Francisco Daniel Muñoz, Palomo-Bravo, Ángeles, Marco, Pascual, Bello, Ihosvany Fernández
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430102/ http://dx.doi.org/10.1097/01.HS9.0000973348.15230.53

Ejemplares similares

Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity
por: Fernández-Bello, Ihosvany, et al.
Publicado: (2013)

Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab
por: Glonnegger, Hannah, et al.
Publicado: (2022)

P1626: A SINGLE-CENTER EXPERIENCE IN INCREASING FACTOR VIII LEVELS TO ACHIEVE ZERO BLEEDING IN PATIENTS WITH SEVERE HEMOPHILIA A.
por: López, Rubén Clavero, et al.
Publicado: (2023)

Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19
por: Montaño, Adrián, et al.
Publicado: (2022)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
por: Monzón Manzano, Elena, et al.
Publicado: (2020)

Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (rIX‐FP): A case report
por: López‐Jaime, Francisco José, et al.
Publicado: (2023)

Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis
por: Pipe, Steven W., et al.
Publicado: (2023)

Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
por: Garcia, Jessica, et al.
Publicado: (2023)

P1629: DISCONTINUATION OF TREATMENT WITH THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE-CENTER CLINICAL EXPERIENCE
por: Santano, Ana María Mena, et al.
Publicado: (2023)

Plague in India in 1618: The Rat Theory Foreshadowed
Publicado: (1919)

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
por: Levy-Mendelovich, Sarina, et al.
Publicado: (2021)

Emicizumab-induced photosensitivity
por: Asensi Cantó, Pedro, et al.
Publicado: (2022)

Emicizumab dose up‐titration in case of suboptimal bleeding control in people with haemophilia A
por: Schmitt, Christophe, et al.
Publicado: (2022)

P1656: PROGRESSIVE WORSENING OF PROTHROMBOTIC PROFILE IN PATIENTS WITH AGGRESSIVE LYMPHOMA ON CHEMOTHERAPY
por: Jaime, Francisco José López, et al.
Publicado: (2023)

Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII
por: Jonsson, Fredrik, et al.
Publicado: (2021)

Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI
por: Kaiser, Rainer, et al.
Publicado: (2022)

Emicizumab state‐of‐the‐art update
por: Mahlangu, Johnny, et al.
Publicado: (2022)

Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients
por: López-Jaime, Francisco José, et al.
Publicado: (2022)

Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan
por: Matsumoto, Naoki, et al.
Publicado: (2023)

Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report
por: Warren, Beth Boulden, et al.
Publicado: (2021)

The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
por: Donners, Anouk A.M.T., et al.
Publicado: (2023)

Book Review: Pharmacopoeias and related literature in Britain and America, 1618–1847
por: Wilson, Renate
Publicado: (2004)

Emicizumab Associated Rhabdomyolysis in Hemophilia A
por: Wilson, Joseph A., et al.
Publicado: (2020)

The dosing conundrum of emicizumab: To waste product or not?
por: Young, Guy
Publicado: (2023)

Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A
por: Retout, Sylvie, et al.
Publicado: (2020)

Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective
por: Camelo, Ricardo Mesquita, et al.
Publicado: (2023)

Anti-emicizumab antibodies do not cross-react with mim8 in vitro
por: Valsecchi, Carla, et al.
Publicado: (2023)

Crisis of Japanese Vascular Flora Shown By Quantifying Extinction Risks for 1618 Taxa
por: Kadoya, Taku, et al.
Publicado: (2014)

Utilization of Emicizumab in Acquired Factor VIII Deficiency
por: Hess, Kevin J., et al.
Publicado: (2020)

Low immunogenicity of emicizumab in persons with haemophilia A
por: Schmitt, Christophe, et al.
Publicado: (2021)

Management of acquired haemophilia A in severe Covid‐19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis
por: Gelbenegger, Georg, et al.
Publicado: (2022)

William Butler (1535-1618): further evidence on a physician between two ages.
por: Boss, J
Publicado: (1977)

Correction: Crisis of Japanese Vascular Flora Shown By Quantifying Extinction Risks for 1618 Taxa
Publicado: (2014)

1618. Meropenem-vaborbactam vs standard of care for multidrug resistant carbapenem-resistant Enterobacteriaceae
por: Misikir, Helina, et al.
Publicado: (2020)

Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia
por: Aliotta, Alessandro, et al.
Publicado: (2020)

Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3
por: Callaghan, Michael U., et al.
Publicado: (2022)

The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome
por: Ranucci, Marco, et al.
Publicado: (2020)

Disruptive technology and hemophilia care: The multiple impacts of emicizumab
por: Hermans, Cedric, et al.
Publicado: (2021)

P1616: EMICIZUMAB FOR THE MANAGEMENT OF ACQUIRED HEMOPHILIA A
por: Sridharan, Meera, et al.
Publicado: (2023)

Spontaneous bleeding of hepatocellular carcinoma during pregnancy
por: Scioscia, Marco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h6h7q2v6810sqaadggbnoij44e